Differential Diagnosis between Uterine Myoma and Endometriosis using CA 125 as a New Tumor Marker of Ovarian Carcinoma

Kentaro Takahashi, Takahashi K, K. Takahashi, Satoshi Kijima, S Kijima, Kijima S, Yoshino K, K. Yoshino, Kazuo Yoshino, T Shibukawa, Toshihiko Shibukawa, Shibukawa T, F Murao, Fuminori Murao, Murao F, M Kitao, Manabu Kitao, Kitao M
Asia-Oceania journal of obstetrics and gynaecology · 1986 · vol. 12(1) , pp. 99–103 · doi:10.1111/j.1447-0756.1986.tb00167.x · PMID:3459417 · W2042959797
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

CA 125 levels were significantly higher in patients with adenomyosis and endometriosis compared to those with uterine myoma, suggesting its utility in preoperative differentiation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract For a preoperative differentiation between leiomyomata uteri and adenomyosis, we measured serum levels of the antigen CA 125, which is specific to ovarian non‐mucinous epithelial carcinoma, in patients with benign gynecologic diseases (39 leiomyomata uteri, 10 adenomyosis, 4 adenomyosis with leiomyomata uteri, 3 adenomyosis with external endometriosis and 4 external endometriosis). Using radio‐immunoassay (RIA) kit, we found the normal range of CA 125 levels to be below 34 U/ml. The mean CA 125 level (±S.D.) was 20.3 ± 10.3 U/ml in patients with leiomyomata uteri and 151.2 ± 157.3 U/ml in those with adenomyosis. The mean CA 125 level in patients with leiomyomata uteri was not statistically higher than that in disease‐free women. The mean CA 125 level in patients with adenomyosis was statistically higher than that in disease‐free women. Of 17 patients with surgically demonstrable adenomyosis, the CA 125 values were over 34 U/ml in 16 (94.1%). Three (75%) of 4 patients with surgically demonstrable external endometriosis had a serum CA 125 level in excess of 34 U/ml. Of 39 patients with surgically demonstrable leiomyomata uteri, CA 125 levels were below 34 U/ml in 37 (94%). CA 125 levels in patients with adenomyosis gradually decreased postoperatively and all were below 34 U/ml within four weeks. Using this approach, leiomyomata uteri and adenomyosis can be differentiated preoperatively and the response to treatment in patients with endometriosis can be monitored.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Antigens, Neoplasm Endometriosis Leiomyoma Uterine Neoplasms Antigens, Neoplasm Antigens, Tumor-Associated, Carbohydrate Diagnosis, Differential Endometriosis Endometriosis Female Humans Leiomyoma Leiomyoma Uterine Neoplasms Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (7)

Cited by (5)

Source provenance

europepmc
last seen: 2026-08-22T06:09:51.966504+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:40.384591+00:00
unpaywall
last seen: 2026-08-22T06:23:50.750314+00:00
License: CC0 · commercial use OK